Samsung, Biogen Co-Operate Amid Italian Antitrust Investigation Into Biosimilar Lucentis

Byooviz Biosimilar Not Available In Italy After August 2021 MAA; Conduct ‘Anomalous’

 
• By Dean Rudge
Many Hands Holding the Red Word Competition, Isolated
• Source: Shutterstock

More from Regulation

More from Policy & Regulation